Overview
Background
Prof Holtmann is a Clinical Academic in the field of Gastroenterology & Hepatology and Director of Clinical Innovation. He is also Director of the Department of Gastroenterology & Hepatology at the Princess Alexandra Hospital in Queensland and serves on the Board of Directors of the West Moreton Hospital and Health Service and UQ Healthcare. He is a Fellow of Royal Australian Collge of Physicians (RACP, Sydney), the Royal College of Physicians (RCP, London) and Fellow of the Australian Academy of Health and Medical Sciences (AAHMS, Canberra). Besides his Medical Qualifications he also obtained a Master of Business Administration. After completing the clinical training in Medicine and Gastroenterology at the University of Essen in Germany and the Mayo Clinic in Rochester, Minnesota in the United States, he has gained substantial leadership and managerial experience within the health care setting as Director of large Gastroenterology Departments, CEO and General Manager of a University Hospital and Health Care Facilities and has served on the Board of the University Hospital Essen in Germany. His research is in the field of Neurogastroenterology has resulted in peer reviewed publications in key journal including the NEJM, Lancet, Gastroenterology and Gut. More recently his rersearch focus is on the role of the gut microbiome, mucosal and systemic inflammation and brain-gut interactions.
Availability
- Professor Gerald Holtmann is:
- Available for supervision
- Media expert
Works
Search Professor Gerald Holtmann’s works on UQ eSpace
2020
Journal Article
Baseline quantitative histology in therapeutics trials reveals villus atrophy in most patients with coeliac disease who appear well controlled on gluten‐free diet
Daveson, A. James M., Popp, Alina, Taavela, Juha, Goldstein, Kaela E., Isola, Jorma, Truitt, Kenneth E., Mäki, Markku, Anderson, Robert P., on behalf of the RESET CeD Study Group, Adams, A., Andrews, J., Behrend, C., Brown, G., Chen Yi Mei, S., Coates, A., Daveson, A.J., DiMarino, A., Elliott, D., Epstein, R., Feyen, B., Fogel, R., Friedenberg, K., Gearry, R., Gerdis, M., Goldstein, M., Gupta, V., Holmes, R., Holtmann, G., Idarraga, S. ... Wilson, S. (2020). Baseline quantitative histology in therapeutics trials reveals villus atrophy in most patients with coeliac disease who appear well controlled on gluten‐free diet. GastroHep, 2 (1), 22-30. doi: 10.1002/ygh2.380
2019
Conference Publication
Functional Gastrointestinal Disorders (FGIDs) patients benefit from a 12-weeks multidisciplinary integrated treatment approach to reduce gastrointestinal symptoms, anxiety and depressive symptoms
Bray, Nicola, Koloski, Natasha, Jones, Michael, Do, Anh, Talley, Nicholas, Billin, Abbi, Bettens, Gemma, Mcallister, Sarah, Pang, Siong, Arthur, Leela, Campos, Jane, Chao, Jeff and Holtmann, Gerald (2019). Functional Gastrointestinal Disorders (FGIDs) patients benefit from a 12-weeks multidisciplinary integrated treatment approach to reduce gastrointestinal symptoms, anxiety and depressive symptoms. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW), Adelaide, SA, Australia, 8–10 September 2019. Hoboken, NJ, United States: Wiley-Blackwell.
2019
Conference Publication
Diagnostic yield and healthcare resource utilization of Eesophagogastroduodenoscopy in patients referred for colonoscopy for investigation of positive Fecal Occult Blood Test (FOBT plus )
Shah, Ayesha, Kutyla, Marguerite, Hansen, Teressa, Virgo, Kate, Koloski, Natasha, Huelsen-Katz, Alexander, Martin, Neal, Maqboul, Nadia, Chao, Che-Yung, Whaley, Amanda, Hourigan, Luke and Holtmann, Gerald (2019). Diagnostic yield and healthcare resource utilization of Eesophagogastroduodenoscopy in patients referred for colonoscopy for investigation of positive Fecal Occult Blood Test (FOBT plus ). Asia Pacific Digestive Week (APDW), Kolkata, India, 12–15 December 2019. Richmond, VIC Australia: John Wiley & Sons.
2019
Journal Article
Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease
Daveson, A. James M., Tye-Din, Jason A., Goel, Gautam, Goldstein, Kaela E., Hand, Holly L., Neff, Kristin M., Williams, Leslie J., Truitt, Kenneth E., Anderson, Robert P., on behalf of the RESET CeD Study Group, Adams, A., Andrews, J., Behrend, C., Brown, G., Mei, S. Chen Yi, Coates, A., Daveson, A. J. M., DiMarino, A., Ee, H., Elliott, D., Epstein, R., Feyen, B., Fogel, R., Friedenberg, K., Gearry, R., Gerdis, M., Goldstein, M., Gupta, V., Holmes, R. ... Wilson, S. (2019). Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease. Alimentary Pharmacology & Therapeutics, 51 (2), 244-252. doi: 10.1111/apt.15551
2019
Conference Publication
A 12-week multidisciplinary integrated treatment approach is superior to standard care for symptom reduction in patients with functional gastrointestinal disorders: A case-control study
Bray, N., Koloski, N., Jones, M., Do, A., Talley, N., Billin, A., Bettens, G., McAllister, S., Pang, S., Arthur, L., Campos, J., Chao, C., Catague, R., Whalley, A., MacDonald, G. and Holtmann, G. (2019). A 12-week multidisciplinary integrated treatment approach is superior to standard care for symptom reduction in patients with functional gastrointestinal disorders: A case-control study. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW), Adelaide, SA, Australia, 8–10 September 2019. Hoboken, NJ, United States: Wiley-Blackwell.
2019
Conference Publication
A hospital-based, multidisciplinary approach to lifestyle management is effective in patients with non-alcoholic fatty liver disease
Britton, L., Stewart, A., Campos, J., Robertson, T., Mcallister, S., De Maria, K., Catague, R., Wright, P., Holtmann, G. and MacDonald, G. (2019). A hospital-based, multidisciplinary approach to lifestyle management is effective in patients with non-alcoholic fatty liver disease. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) “The Universe Within”, Adelaide, SA, Australia, 8–10 September 2019. Richmond, VIC, Australia: Wiley-Blackwell.
2019
Conference Publication
Patients with functional gastrointestinal disorders benefit from a 12-week multidisciplinary integrated treatment approach to reduce anxiety and depressive symptoms
Bray, N., Koloski, N., Jones, M., Do, A., Talley, N., Billin, A., Bettens, G., Mcallister, S., Pang, S., Arthur, L., Campus, J., Chao, C., Catague, R., Whaley, A., Macdonald, G. and Holtmann, G. (2019). Patients with functional gastrointestinal disorders benefit from a 12-week multidisciplinary integrated treatment approach to reduce anxiety and depressive symptoms. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW), Adelaide, SA, Australia, 8–10 September 2019. Hoboken, NJ, United States: Wiley-Blackwell.
2019
Journal Article
The use of modelling studies to inform planning of health services: case study of rapidly increasing endoscopy services in Australia
Carter, Hannah E., Knowles, Dylan, Moroney, Timothy, Holtmann, Gerald, Rahma, Tony, Appleyard, Mark, Steele, Nick, Zanco, Michael and Graves, Nicholas (2019). The use of modelling studies to inform planning of health services: case study of rapidly increasing endoscopy services in Australia. BMC Health Services Research, 19 (1) 608, 608. doi: 10.1186/s12913-019-4438-x
2019
Journal Article
Dysbiosis of the Duodenal Mucosal Microbiota Is Associated With Increased Small Intestinal Permeability in Chronic Liver Disease
Raj, Ashok S., Shanahan, Erin R., Tran, Cuong D., Bhat, Purnima, Fletcher, Linda M., Vesey, David A., Morrison, Mark, Holtmann, Gerald and Macdonald, Graeme A. (2019). Dysbiosis of the Duodenal Mucosal Microbiota Is Associated With Increased Small Intestinal Permeability in Chronic Liver Disease. Clinical and Translational Gastroenterology, 10 (8) e00068, e00068. doi: 10.14309/ctg.0000000000000068
2019
Journal Article
Circulating Anti-cytolethal Distending Toxin B and Anti-vinculin Antibodies as Biomarkers in Community and Healthcare Populations With Functional Dyspepsia and Irritable Bowel Syndrome
Talley, Nicholas J., Holtmann, Gerald, Walker, Marjorie M., Burns, Grace, Potter, Michael, Shah, Ayesha, Jones, Michael, Koloski, Natasha A. and Keely, Simon (2019). Circulating Anti-cytolethal Distending Toxin B and Anti-vinculin Antibodies as Biomarkers in Community and Healthcare Populations With Functional Dyspepsia and Irritable Bowel Syndrome. Clinical and Translational Gastroenterology, 10 (7) e-00064, e00064. doi: 10.14309/ctg.0000000000000064
2019
Conference Publication
In-vitro evaluation of antifoaming effects of simethicone: a dose-finding study
Kutyla, Marguerite, Shah, Ayesha, Meeusen, Vera, Elson, Jerome, Heulsen-Katz, Alex, Hourigan, Luke F. and Holtmann, Gerald J. (2019). In-vitro evaluation of antifoaming effects of simethicone: a dose-finding study. Digestive Disease Week (DDW), San Diego, CA United States, 18-21 May 2019. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.gie.2019.03.070
2019
Journal Article
An in vitro and clinical dose-finding study of antifoaming effects of simethicone during colonoscopy
Kutyla, Marguerite J., Shah, Ayesha, Elson, Jerome, Meeusen, Vera, O’Connor, Sam, Hourigan, Luke F. and Holtmann, Gerald J. (2019). An in vitro and clinical dose-finding study of antifoaming effects of simethicone during colonoscopy. Indian Journal of Gastroenterology, 38 (3), 268-272. doi: 10.1007/s12664-019-00966-3
2019
Conference Publication
Weight loss and metabolic improvements one year after treatment with a duodenal-jejunal bypass sleeve (Endobarrier (R))
McMaster, Jessica J., Shanahan, Erin R., Anh Do,, Rich, Graeme, Veronique, Chachay, Macdonald, Graeme A. and Holtmann, Gerald J. (2019). Weight loss and metabolic improvements one year after treatment with a duodenal-jejunal bypass sleeve (Endobarrier (R)). Digestive Disease Week (DDW), San Diego, CA USA, 18-21 May 2019. Philadelphia, PA USA: Elsevier.
2019
Journal Article
Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease
Shah, Ayesha, Morrison, Mark, Burger, Daniel, Martin, Neal, Rich, Justin, Jones, Mike, Koloski, Natasha, Walker, Marjorie M., Talley, Nicholas J. and Holtmann, Gerald J. (2019). Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 49 (6), 624-635. doi: 10.1111/apt.15133
2019
Journal Article
Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress
Koloski, Natasha, Jones, Michael, Walker, Marjorie M., Veysey, Martin, Zala, Alkesh, Keely, Simon, Holtmann, Gerald and Talley, Nicholas J. (2019). Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress. Alimentary Pharmacology and Therapeutics, 49 (5), 546-555. doi: 10.1111/apt.15120
2019
Journal Article
The impact of peppermint oil on the irritable bowel syndrome: A meta-analysis of the pooled clinical data 11 Medical and Health Sciences 1103 Clinical Sciences
Alammar, N., Wang, L., Saberi, B., Nanavati, J., Holtmann, G., Shinohara, R. T. and Mullin, G. E. (2019). The impact of peppermint oil on the irritable bowel syndrome: A meta-analysis of the pooled clinical data 11 Medical and Health Sciences 1103 Clinical Sciences. BMC Complementary and Alternative Medicine, 19 (1) 21, 21. doi: 10.1186/s12906-018-2409-0
2019
Conference Publication
273 – A Multidisciplinary Integrated Treatment Approach is Superior to Standard Care for Functional Gastrointestinal Disorders (FGIDS): A Case-Control Study
Bray, Nicola, Koloski, Natasha A., Jones, Michael P., Do, Anh, Talley, Nicholas J., McAllister, Sarah, Pang, Siong, Arthur, Leela, Campos, Jane, Chao, Che-yung, Billin, Abi, Bettens, Gemma, Catague, Rachel, Whaley, Amanda, Macdonald, Graeme A. and Holtmann, Gerald J. (2019). 273 – A Multidisciplinary Integrated Treatment Approach is Superior to Standard Care for Functional Gastrointestinal Disorders (FGIDS): A Case-Control Study. Digestive Disease Week 2019, San Diego, CA, United States, 18-21 May 2019. PHILADELPHIA: Elsevier BV. doi: 10.1016/s0016-5085(19)36917-3
2019
Journal Article
Effects of antibiotic therapy in primary sclerosing cholangitis with and without inflammatory bowel disease: a systematic review and meta-analysis
Shah, Ayesha, Crawford, Darrel, Burger, Daniel, Martin, Neal, Walker, Marjorie, Talley, Nicholas J., Tallis, Caroline, Jones, Michael, Stuart, Katherine, Keely, Simon, Lewindon, Peter, MacDonald, Graeme A., Morrison, Mark and Holtmann, Gerald J. (2019). Effects of antibiotic therapy in primary sclerosing cholangitis with and without inflammatory bowel disease: a systematic review and meta-analysis. Seminars in Liver Disease, 39 (4), 432-441. doi: 10.1055/s-0039-1688501
2019
Conference Publication
Tu1618 – Patients with Functional Gastrointestinal Disorders (FGIDS) Benefit from a Multidisciplinary Integrated Treatment Approach to Reduce Anxiety and Depressive Symptoms
Bray, Nicola, Koloski, Natasha A., Jones, Michael P., Do, Anh, Talley, Nicholas J., Billin, Abi, Bettens, Gemma, McAllister, Sarah, Pang, Siong, Arthur, Leela, Campos, Jane, Chao, Che-Yung, Catague, Rachel, Whaley, Amanda, Macdonald, Graeme A. and Holtmann, Gerald (2019). Tu1618 – Patients with Functional Gastrointestinal Disorders (FGIDS) Benefit from a Multidisciplinary Integrated Treatment Approach to Reduce Anxiety and Depressive Symptoms. Digestive Disease Week, San Diego, CA, United States, 18-21 May, 2019. PHILADELPHIA: Elsevier BV. doi: 10.1016/s0016-5085(19)39623-4
2019
Conference Publication
Factorial analysis-based assessment of the Mucosa Associated Microbiome
Holtmann, Gerald, Morrison, Mark, Talley, Nicholas, Koloski, Natasha, Shah, Ayesha and Jones, Michael (2019). Factorial analysis-based assessment of the Mucosa Associated Microbiome. Asia Pacific Digestive Week, Kolkata, India, 12–15 December 2019. Hoboken, NJ United States: Wiley.
Funding
Current funding
Past funding
Supervision
Availability
- Professor Gerald Holtmann is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Effects the COVID-19 pandemic on the outcome and management of highly prevalent gastrointestinal conditions
Principal Advisor
Other advisors: Dr Ayesha Shah
-
Doctor Philosophy
IBD and mental health tools: a holistic approach to discovery and appropriate tool.
Principal Advisor
Other advisors: Dr Ayesha Shah
-
Doctor Philosophy
Targeting the gastrointestinal mucosa associated microbiome to improve clinical outcomes
Associate Advisor
Other advisors: Dr Ayesha Shah
-
Doctor Philosophy
The role of the gut microbiome in alcohol related liver disease
Associate Advisor
Other advisors: Professor Jason Connor, Dr Paul Clark
-
Doctor Philosophy
Study of TOfacitinib for the treatment of chronic Pouchitis
Associate Advisor
Other advisors: Associate Professor Jakob Begun
-
Doctor Philosophy
Exercise training on people with severe chronic, clinically unexplained gastrointestinal symptoms: A randomised, controlled trial.
Associate Advisor
Other advisors: Professor Jeff Coombes
Completed supervision
-
2025
Doctor Philosophy
Reimagining Health Equity and Access in Colorectal Cancer Screening. A population perspective.
Principal Advisor
Other advisors: Dr Ayesha Shah
-
2020
Doctor Philosophy
Characterization of the Human Duodenal Microbiome in Health and Disease
Principal Advisor
Other advisors: Associate Professor Graeme Macdonald
-
2019
Doctor Philosophy
Mechanisms of action of the duodenal-jejunal bypass sleeve
Principal Advisor
Other advisors: Associate Professor Graeme Macdonald
-
2023
Doctor Philosophy
Structure-function relationships of the mucosa-associated microbiota in Crohn's disease
Associate Advisor
Other advisors: Associate Professor Jakob Begun, Professor Mark Morrison
-
2022
Doctor Philosophy
Multi-omics data offer systemic insights into autism
Associate Advisor
Other advisors: Professor Naomi Wray, Honorary Professor Jake Gratten
-
2022
Doctor Philosophy
Genomic- and culture-enabled analyses of host-associated methanogenic archaea
Associate Advisor
Other advisors: Professor Mark Morrison
-
Doctor Philosophy
The role of small intestinal permeability and gut microbiota in chronic liver disease
Associate Advisor
Other advisors: Associate Professor Graeme Macdonald
Media
Enquiries
Contact Professor Gerald Holtmann directly for media enquiries about:
- colon cancer screening
- Gastroenterology
- Gut Health
- Microbiome
- Neurogastroenterology
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: